MalmbergKRydenLHamstenA. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI (Diabetes Insulin-Glucose in Acute Myocardial Infarction) Study Group. Eur Heart J1996; 17: 1337–1344.
2.
ScottJ. F.; GrayC. S.; O'ConnellJ. E.; AlbertiK. G. M. M.Glucose and insulin therapy in acute stroke; why delay further?Qjm1998; 91: 511–515.
3.
LairdAMMillerPRKilgoPDMeredithJWChangMC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma-Injury Infection & Critical Care2004; 56: 1058–62.
4.
Van den BergheGWoutersPWeekersF. Intensive Insulin Therapy in Critically III Patients. NEJM2001. 345: 1359–1367.
5.
CariouAVinsonneauCDhainautJ-F. Adjunctive therapies in sepsis: An evidence-based review. CCM2004; 32: S562–S570.
6.
The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med2000; 342: 1301–1308.
7.
BernardGRVincentJLLaterrePF: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med2001; 344: 699–709.
8.
AnnaneD.SebilleV.CharpentierC.. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA2002; 288 (7): 862–71.